Galaxy Surfactants: Business Overview & Financial Analysis
Galaxy Surfactants is a premier Indian specialty chemicals manufacturing enterprise headquartered in Navi Mumbai, Maharashtra. Promoted by Unnathan Shekhar and managed by Managing Director K. Natarajan, the enterprise processes fatty alcohols and ethylene oxide to produce performance surfactants and specialty care ingredients. Serving top-tier global fast-moving consumer goods (FMCG) brand owners in the home and personal care (HPC) industry, Galaxy Surfactants exports active formulations across 80+ countries.
Business Segment Revenue Mix of Galaxy Surfactants (Q1 FY2027)
Galaxy Surfactants structures its consolidated operational turnover across primary performance surfactants and high-value specialty care products.
- Performance Surfactants Division Share – 66.2% of Total Segment Revenue (Rs 1,178.70 crore)
- Specialty Care Products Division Share – 33.8% of Total Segment Revenue (Rs 603.20 crore)
- Total Segment Revenue Realised (Q1 FY2027) – Rs 1,781.90 crore (+39.4% YoY)
- Performance Surfactants YoY Growth Rate – +35.2% YoY turnover expansion
- Specialty Care Products YoY Growth Rate – +48.5% YoY turnover expansion
Performance surfactants generate high-volume base revenue by supplying cleansing agents to shampoo and detergent brand owners. High-value specialty care products deliver higher profit margins through sunscreens, mild surfactants, and preservatives.
Regional Market Volume & Geographic Mix of Galaxy Surfactants (Q1 FY2027)
The enterprise balances its global product dispatches across domestic Indian markets, Africa, Middle East and Turkey (AMET), and Rest of the World (ROW) territories.
- India Market Volume Growth Rate – Low double-digit YoY volume growth
- AMET Region Volume Performance – Low single-digit YoY volume dip (+15%+ QoQ recovery)
- Rest of the World (ROW / Americas & APAC) Growth Rate – Mid single-digit YoY volume growth
- Global Export Footprint Reach – Active sales dispatches across 80+ countries
- Key Growth Driver Region – Domestic India market outperforming market growth
Rebounding domestic demand in India drove double-digit volume expansion as Tier-1 FMCG clients restored order volumes. Sequential volume recovery across the AMET region offset temporary supply chain friction caused by Middle East trade disruptions.
Product Portfolio & Formulations Scale of Galaxy Surfactants (FY2026)
Galaxy Surfactants manages an ingredient catalog spanning core cleansing surfactants, mild skin care agents, and preservation platforms.
- Active Commercial Product Grades Portfolio – 215+ registered product grades
- Core Product Families Managed – Surfactants, sunscreens, hair care conditioning agents, and preservatives
- Proprietary Green Surfactant Range – Amino acid-based mild cleansers and bio-based ingredients
- Primary Customer Industry Base – Home and Personal Care (HPC) multinational majors
- Global Patent Applications Base – 80+ patents granted and filed globally
Operating 215+ product grades enables deep vendor integration with global personal care manufacturers. Expanding green, bio-based amino acid surfactants satisfies rising global consumer demand for eco-friendly personal care formulations.
Manufacturing Infrastructure & Plant Scale of Galaxy Surfactants (Q1 FY2027)
Galaxy Surfactants manages an integrated global manufacturing footprint equipped with automated sulfonation, ethoxylation, and esterification plants.
- Total Operational Manufacturing Complexes Base – 7 manufacturing plants globally
- Domestic Indian Plants Base – 5 facilities across Tarapur, Taloja (Maharashtra), and Jhagadia (Gujarat)
- Overseas International Plants Base – 2 facilities located in Suez (Egypt) and New Hampshire (USA)
- Total Installed Manufacturing Capacity Base – 500,000+ Metric Tonnes Per Annum (MTPA)
- In-House R&D Center Scale – Innovation centers in Navi Mumbai with 70+ research scientists
Five domestic manufacturing units in Maharashtra and Gujarat handle primary synthesis and customer order fulfillment. Overseas plants in Egypt and the United States provide localized delivery to European and American personal care brand owners.
Operational KPIs & Unit Economics of Galaxy Surfactants (Q1 FY2027)
Galaxy Surfactants tracks quarterly dispatch volumes, unit EBITDA profitability per metric tonne, and raw material cost pass-through efficiency.
- First-Quarter Volume Growth Rate – Mid single-digit YoY volume expansion
- Consolidated EBITDA Per Metric Tonne Realisation – Rs 35,458 per MT (+77.2% YoY vs Rs 20,009/MT)
- Full-Year EBITDA Guidance (FY2027) – Raised to Rs 24,000–25,000 per MT
- Full-Year Volume Growth Target Guidance – 6.0% to 8.0% annual volume CAGR
- Operating EBITDA Margin Realisation – 14.10% (+360 bps YoY)
Operating EBITDA per metric tonne surged to Rs 35,458 driven by favorable product mix enrichment and pricing discipline. Raising full-year EBITDA guidance to Rs 24,000–25,000 per tonne highlights management confidence in unit economics.
Latest Quarterly Financial Performance of Galaxy Surfactants (Q1 FY2027)
Galaxy Surfactants recorded record quarterly top-line turnover expansion and operating profit growth during the first quarter of FY2027.
- Consolidated Revenue from Operations – Rs 1,781.90 crore (+39.4% YoY vs Rs 1,277.90 crore)
- Consolidated Total Income – Rs 1,785.20 crore (+38.5% YoY vs Rs 1,289.20 crore in Q1 FY2026)
- Consolidated Operating EBITDA – Rs 252.50 crore (+86.9% YoY vs Rs 135.10 crore in Q1 FY2026)
- Consolidated Net Profit After Tax (PAT) – Rs 165.90 crore (+108.7% YoY vs Rs 79.50 crore in Q1 FY2026)
- Net PAT Margin Realisation – 9.30% (+310 bps YoY vs 6.20%)
First-quarter revenue rose 39.4% year-on-year to Rs 1,781.90 crore, driven by pricing actions and domestic volume recovery. Operating EBITDA surged 86.9% to a record Rs 252.50 crore, while Net Profit After Tax doubled to Rs 165.90 crore.
Consolidated Annual Financial Performance of Galaxy Surfactants (FY2026)
Galaxy Surfactants delivered full-year operational turnover and cash generation during full financial year FY2026 despite global geopolitical headwinds.
- Full Year Revenue from Operations – Rs 5,248.28 crore (FY2026)
- Full Year Consolidated Operating EBITDA – Rs 497.40 crore (FY2026)
- Full Year Consolidated Net Profit After Tax (PAT) – Rs 267.40 crore (FY2026)
- Full Year Final Equity Dividend Declared – Rs 22.00 per equity share
- Fourth-Quarter EBITDA Realisation (Q4 FY2026) – Rs 121.90 crore
Full-year operating turnover crossed Rs 5,240 crore in FY2026, as consolidated Net Profit After Tax reached Rs 267.40 crore. Strong cash accruals supported a final dividend payout of Rs 22.00 per share for shareholders.
Balance Sheet Structure & Financial Health Ratios of Galaxy Surfactants (Q1 FY2027)
Galaxy Surfactants operates a net debt-free financial structure supported by equity retention and liquid cash reserves.
- Financial Debt Gearing Status – Net Debt-Free / Net Cash Positive
- Debt to Equity Ratio – ~0.05x (Negligible borrowing leverage)
- Total Shareholder Equity Net Worth Base – ~Rs 2,150.00 crore
- Return on Equity (ROE) Realisation – 16.0%
- Working Capital Conversion Cycle – Disciplined inventory and trade receivables management
Maintaining a net debt-free balance sheet with a 0.05x debt-to-equity ratio provides full financial independence. Strong net worth of Rs 2,150.00 crore ensures capital availability for ongoing brownfield manufacturing debottlenecking.
Capex Allocation & Expansion Roadmap of Galaxy Surfactants (FY2027)
Galaxy Surfactants executes capital allocation outlays dedicated to expanding specialty care production lines and upgrading green chemical infrastructure.
- Planned Annual Capex Outlay Guidance – Rs 150.00 to Rs 180.00 crore per annum
- Primary Capacity Allocation Focus – Specialty care ingredients and mild amino acid surfactants
- Jhagadia Plant Debottlenecking Target – Expanding ethoxylation and specialty synthesis reactors
- Solar & Renewable Power Integration – Increasing captive solar power sourcing across Gujarat plants
- Funding Method – 100% funded through internal operational cash accruals
Annual capital expenditure budgets allocate Rs 150–180 crore to debottleneck specialty ingredient production lines. Internal operational cash flow generation fully funds all planned capex projects without debt borrowing.
Management Commentary & Strategic Outlook of Galaxy Surfactants (Q1 FY2027 Concall)
Management guidance outlines strategic priorities centered on specialty mix enrichment, volume growth recovery, and unit margin preservation.
- Annual Volume Growth Target Guidance – Projected 6.0% to 8.0% YoY volume expansion for full financial year FY2027.
- Full-Year EBITDA Guidance Revision – Raised unit margin guidance to Rs 24,000–25,000 per MT.
- Domestic Market Outlook – Low double-digit volume growth trajectory expected to sustain in India.
- AMET Region Strategy – Navigating Middle East logistics constraints through agile pricing actions.
- Specialty Care Segment Focus – Driving customer adoption of sustainable, bio-based specialty ingredients.
- Capital Allocation Strategy – Reinvesting internal cash flows into brownfield expansions while maintaining zero net debt.
Management anticipates delivering 6%–8% volume growth in FY2027, backed by domestic FMCG demand recovery. Operational focus centers on capturing specialty care market share, managing raw material volatility, and preserving cash reserves.
Want to filter out stocks based on your own investment criteria? You can use the Stock Screener on Finology Ticker to evaluate stocks based on customised valuation and profitability parameters.
Sources & References
- Galaxy Surfactants Q1 FY2027 Consolidated Financial Results Disclosures & Investor Outcomes (August 2026)
- Galaxy Surfactants Q4 FY2026 & FY2026 Financial Results Analysis & Press Release (May/August 2026)
- Galaxy Surfactants Corporate Announcements & AGM Disclosures (August 12, 2026)
- BSE Limited & National Stock Exchange of India (NSE) Corporate Filings for Galaxy Surfactants
- Ticker Finology Galaxy Surfactants Page
Disclaimer
The information presented above on Galaxy Surfactants has been compiled from the company's Annual Reports, Investor Presentations, Earnings Call (Concall) Transcripts, official regulatory filings and the financial data available on Finology Ticker. Certain figures, classifications or comparisons may vary due to differences in accounting policies, reporting methodologies or subsequent restatements by the company. This content is intended solely for informational purposes and should not be considered as investment advice. Investors are advised to refer to the latest company filings and the updated financial data, ratios and disclosures available on this Finology Ticker Galaxy Surfactants page before making any investment decision. Investment in securities market are subject to market risks. Read all the related documents carefully before investing.